This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Aug 18;118(7):1711-2.

doi: 10.1182/blood-2011-06-359737.

3 Rs: rituximab, remission, relapse

Spero R Cataland¹

Affiliations

PMID: 21852440
DOI: 10.1182/blood-2011-06-359737

Free article

Comment

3 Rs: rituximab, remission, relapse

Spero R Cataland. Blood. 2011.

Free article

. 2011 Aug 18;118(7):1711-2.

doi: 10.1182/blood-2011-06-359737.

Author

Spero R Cataland¹

Affiliation

¹ The Ohio State University, USA.

PMID: 21852440
DOI: 10.1182/blood-2011-06-359737

No abstract available

PubMed Disclaimer

Comment on

A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.
Scully M, McDonald V, Cavenagh J, Hunt BJ, Longair I, Cohen H, Machin SJ. Scully M, et al. Blood. 2011 Aug 18;118(7):1746-53. doi: 10.1182/blood-2011-03-341131. Epub 2011 Jun 2. Blood. 2011. PMID: 21636861 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems